XML 78 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Borrowings
9 Months Ended
Sep. 30, 2014
Debt Disclosure [Abstract]  
Borrowings
Note 11 – Borrowings
Match Funded Liabilities
Match funded liabilities are comprised of the following at the dates indicated:
Borrowing Type
 
Interest Rate
 
Maturity (1)
 
Amortization Date (1)
 
Available Borrowing Capacity (2)
 
September 30, 2014
 
December 31, 2013
Advance Receivable Backed Notes Series 2012-ADV1 (3)
 
1ML (4) + 175 bps
 
Jun. 2017
 
Jun. 2015
 
$
130,753

 
$
344,247

 
$
417,388

Advance Receivable Backed
Note
 
1ML + 300 bps
 
Dec. 2015
 
Dec. 2014
 
44,987

 
5,013

 
33,211

2012-Homeward Agency Advance Funding Trust
2012-1 (5)
 
Cost of Funds + 300 bps
 
Apr. 2014
 
Apr. 2014
 

 

 
21,019

Advance Receivables Backed Notes, Series 2013-VF1,
Class A (6)
 
1ML + 175 bps (7)(11)
 
Oct. 2044
 
Oct. 2014
 
156,812

 
843,188

 
1,494,628

Advance Receivables Backed Notes, Series 2013-VF2,
Class A (6)
 
1ML + 167 bps (8)(11)
 
Oct. 2044
 
Oct. 2014
 
75,693

 
408,019

 
385,645

Advance Receivables Backed Notes, Series 2013-VF2,
Class B (6)
 
1ML + 425 bps (9)(11)
 
Oct. 2044
 
Oct. 2014
 
2,711

 
13,577

 
12,923

Advance Receivables Backed Notes - Series 2014-VF3, Class A (10)
 
1ML + 175 bps (10)(11)
 
Oct. 2044
 
Oct. 2014
 
78,405

 
421,595

 

 
 
 
 
 
 
 
 
$
489,361

 
$
2,035,639

 
$
2,364,814

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
1.91
%
 
2.08
%
(1)
The amortization date of our facilities is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the date on which all outstanding balances must be repaid. In two advance facilities, there are multiple notes outstanding. For each note, after the amortization date, all collections that represent the repayment of advances pledged to the facility must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
(2)
Borrowing capacity is available to us provided that we have additional eligible collateral to pledge. Collateral may only be pledged to one facility. At September 30, 2014, only $51.2 million of the available borrowing capacity could be used based on the amount of eligible collateral that had been pledged.
(3)
On October 28, 2014, the maximum borrowing capacity under this facility was reduced to $450.0 million and will further decline to $400.0 million in February 2015.
(4)
1-Month LIBOR (1ML) was 0.16% and 0.17% at September 30, 2014 and December 31, 2013, respectively.
(5)
Advance facility assumed as part of the acquisition of Homeward. This facility was terminated on April 16, 2014, and the advances pledged to the facility were transferred to another facility.
(6)
These notes were issued in connection with the OneWest MSR Transaction. On February 3, 2014, the maximum borrowing capacity on the 2013-VF2 notes was increased by $100.0 million to a total of $500.0 million. On March 17, 2014, the maximum borrowing capacity under the 2013-VF1 note declined by $500.0 million to a total of $1.0 billion. On October 1, 2014, the VF1 note was fully repaid. The maximum borrowing capacity of the VF2, Class A notes was increased to $564.0 million, and the maximum borrowing capacity of the VF2, Class B notes was increased to $36.0 million. In addition, the amortization date of the VF2 Class A and B notes was extended to October 15, 2015, and the maturity date was extended to October 15, 2045. Finally, a new series, the Series 2014-VF4 note, was issued with a maximum borrowing capacity of $600.0 million, an amortization date of October 15, 2015 and a maturity date of October 15, 2045. The interest margin on this new series of notes was set to 175 bps through July 14, 2015, to 200 bps on July 15, 2015, to 212 bps on August 15, 2015 and to 250 bps on September 15, 2015.
(7)
The interest margin on these notes increased to 200 bps on July 15, 2014, to 225 bps on August 15, 2014 and 250 bps on September 15, 2014. 
(8)
The interest margin on these notes increased to 191 bps on July 15, 2014, to 215 bps on August 15, 2014 and 238 bps on September 15, 2014. Effective October 1, 2014, the interest margin on these notes was set to 167 bps through July 14, 2015, to 191 bps on July 15, 2015, to 215 bps on August 15, 2015 and to 239 bps on September 15, 2015.
(9)
The interest margin on these notes increased to 486 bps on July 15, 2014, to 546 bps on August 15, 2014 and 607 bps on September 15, 2014. Effective October 1, 2014, the interest margin on these notes was set to 300 bps through July 14, 2015, to 343 bps on July 15, 2015, to 386 bps on August 15, 2015 and to 429 bps on September 15, 2015.
(10)
This note was issued on March 17, 2014 with a maximum borrowing capacity of $500.0 million. The interest margin on this note increased to 200 bps on July 15, 2014, to 225 bps on August 15, 2014 and 250 bps on September 15, 2014. On October 1, 2014, the maximum borrowing capacity of the note was increased to $600.0 million, the amortization date was extended to October 15, 2015 and the maturity date was extended to October 15, 2045. The interest margin was set to 175 bps through July 14, 2015, to 200 bps on July 15, 2015, to 225 bps on August 15, 2015 and to 250 bps on September 15, 2015.
(11)
On July 15, 2014, the lenders agreed to waive the increase in interest margin scheduled for July 15, 2014. On August 15, 2014, the lenders also agreed to waive the increases in interest margin that were scheduled for August 15, 2014 and September 15, 2014.
Financing Liabilities
Financing liabilities are comprised of the following at the dates indicated:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
September 30, 2014
 
December 31, 2013
Servicing:
 
 
 
 
 
 
 
 
 
 
Financing liability – MSRs pledged
 
MSRs
 
(1)
 
(1)
 
$
618,855

 
$
633,804

Secured Notes, Ocwen Asset Servicing Income Series, Series 2014-1 (2)
 
MSRs
 
(2)
 
Feb. 2028
 
115,039

 

Financing Liability – Advances Pledged (3)
 
Advances on loans
 
(3)
 
(3)
 
87,502

 

 
 
 
 
 
 
 
 
821,396

 
633,804

 
 
 
 
 
 
 
 
 
 
 
Lending:
 
 
 
 
 
 
 
 
 
 
Financing liability - MSRs pledged (4)
 
MSRs
 
(4)
 
(4)
 

 
17,593

HMBS-related borrowings (5)
 
Loans held for investment (LHFI)
 
1ML + 245 bps
 
(5)
 
1,236,094

 
615,576

 
 
 
 
 
 
 
 
1,236,094

 
633,169

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
2,057,490

 
$
1,266,973

(1)
The HLSS Transaction financing liabilities have no contractual maturity. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows underlying the related MSRs. As discussed in Note 1A — Restatement of Previously Issued Consolidated Financial Statements, we are restating our previously reported consolidated operating results for the three and nine months ended September 30, 2013 to correct an error in the accounting applicable to the financing liabilities in connection with Rights to MSRs sold to HLSS.
(2)
OASIS noteholders are entitled to receive a monthly payment amount equal to the sum of: a) the designated servicing fee amount (21 basis points of the UPB of the reference pool of Freddie Mac mortgages); b) any termination payment amounts; c) any excess refinance amounts; and d) the note redemption amounts, each as defined in the indenture supplement for the notes. The notes have a final stated maturity of February 2028. We accounted for this transaction as a financing. Monthly amortization of the liability is estimated using the proportion of monthly projected service fees on the underlying MSRs as a percentage of lifetime projected fees, adjusted for the term of the security.
(3)
Certain advances were sold to HLSS Mortgage and HLSS SEZ LP on March 4, 2014 and May 2, 2014, respectively. These sales of advances did not qualify for sales accounting treatment and were accounted for as a financing. See Note 5 – Loans Held for Sale for additional information.
(4)
Sales of MSRs to a third party accounted for as a financing. The financing liability was being amortized using the interest method with the servicing income that was remitted to the purchaser representing payments of principal and interest. In April 2014, we derecognized the remaining liability related to this MSR sale. During 2014, we recognized a gain of $2.6 million on the extinguishment of the financing liability.
(5)
Represents amounts due to the holders of beneficial interests in Ginnie Mae guaranteed HMBS. The beneficial interests have no maturity dates, and the borrowings mature as the related loans are repaid. See Note 2 – Securitizations and Variable Interest Entities for additional information.
Other Secured Borrowings
Other secured borrowings are comprised of the following at the dates indicated:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
Available Borrowing Capacity
 
September 30, 2014
 
December 31, 2013
Servicing:
 
 
 
 
 
 
 
 
 
 
 
 
SSTL (1)
 
(1)
 
1-Month Euro-dollar rate + 375 bps with a Eurodollar floor of 125 bps (1)
 
Feb. 2018
 
$

 
$
1,280,500

 
$
1,290,250

Promissory note (2)
 
MSRs
 
1ML + 350 bps
 
May 2017
 

 

 
15,529

Repurchase agreement (3)
 
Loans held for sale (LHFS)
 
1ML + 200 - 345 bps
 
Jun. 2015
 
27,338

 
22,662

 
17,507

 
 
 
 
 
 
 
 
27,338

 
1,303,162

 
1,323,286

 
 
 
 
 
 
 
 
 
 
 
 
 
Lending:
 
 
 
 
 
 
 
 
 
 
 
 
Master repurchase agreement (4)
 
LHFS
 
1ML + 175 bps
 
Apr. 2015
 
17,199

 
132,801

 
105,659

Participation agreement (5)
 
LHFS
 
N/A
 
May 2015
 

 
54,369

 
81,268

Master repurchase agreement (6)
 
LHFS
 
1ML + 175 - 275 bps
 
Oct. 2014
 
10,645

 
64,355

 
91,990

Master repurchase agreement (7)
 
LHFS
 
1ML + 175 - 200 bps
 
Nov. 2014
 
99,527

 
50,473

 
89,836

Master repurchase agreement (8)
 
LHFI
 
1ML + 275bps
 
Oct. 2014
 
858

 
36,642

 
51,975

Mortgage warehouse agreement (9)
 
LHFI
 
1ML + 275 bps; floor of 350 bps
 
May 2015
 
35,695

 
24,305

 
34,292

 
 
 
 
 
 
 
 
163,924

 
362,945

 
455,020

 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Items and Other:
 
 
 
 
 
 
 
 
 
 
 
 
Securities sold under an agreement to repurchase (10)
 
Ocwen Real Estate Asset Liquidating Trust 2007-1 Notes
 
Class A-2 notes: 1ML + 200 bps; Class A-3 notes: 1ML + 300 bps
 
Monthly
 

 
4,678

 
4,712

 
 
 
 
 
 
 
 
191,262

 
1,670,785

 
1,783,018

Discount (1)
 
 
 
 
 
 
 

 
(4,358
)
 
(5,349
)
 
 
 
 
 
 
 
 
$
191,262

 
$
1,666,427

 
$
1,777,669

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
4.94
%
 
4.86
%
(1)
This facility had an initial balance of $1.3 billion and was issued with an original issue discount of $6.5 million that we are amortizing over the term of the loan. We are required to repay the principal amount of the borrowings in consecutive quarterly installments of $3.3 million. In addition, we are generally required to use the net cash proceeds (as defined) from any asset sale (as defined) to repay loan principal, subject to a 270-day reinvestment provision (or, in the case of a sale of MSRs, related servicing advances or other related assets to HLSS, we have a 180-day reinvestment provision and the net cash proceeds must be invested in MSRs or related assets, such as advances). We are also required to make mandatory prepayments in certain circumstances based on our corporate leverage ratio (as defined) if we have positive consolidated excess cash flow (as defined) in any fiscal year. The borrowings are secured by a first priority security interest in substantially all of the assets of Ocwen. Borrowings bear interest, at the election of Ocwen, at a rate per annum equal to either (a) the base rate [the greatest of (i) the prime rate in effect on such day, (ii) the federal funds rate in effect on such day plus 0.50% and (iii) the one-month Eurodollar rate (1-Month LIBOR)], plus a margin of 2.75% and a base rate floor of 2.25% or (b) the one month Eurodollar rate, plus a margin of 3.75% with a one month Eurodollar floor of 1.25%. To date, we have elected option (b) to determine the interest rate.
(2)
This note was repaid in full on February 28, 2014.
(3)
Under this repurchase agreement, the lender provides financing on a committed basis for $50.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $50.0 million.
(4)
Under this repurchase agreement, the lender provides financing on a committed basis for $150.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $150.0 million.
(5)
Under this participation agreement, the lender provides financing on an uncommitted basis for $50.0 million to $100.0 million at the discretion of the lender. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans while the loans are financed under the participation agreement.
(6)
Under this repurchase agreement, the lender provides financing on a committed basis for $75.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $75.0 million. On September 2, 2014, the maturity date of this facility was extended to October 2, 2014. On October 2, 2014, the maturity date was further extended to September 1, 2015.
(7)
Under this repurchase agreement, the lender provides financing on a committed basis for $150.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $300.0 million. On October 24, 2014, this facility was repaid in full and terminated.
(8)
On September 2, 2014, the maturity date of this facility was extended to October 2, 2014, and the maximum borrowing capacity was reduced to $37.5 million on a committed basis plus an additional $37.5 million on an uncommitted basis at the discretion of the lender. On October 1, 2014, the maturity date was extended to October 31, 2014. Effective October 31, 2014, the maturity date was further extended to November 14, 2014.
(9)
In August 2014, the maturity date of this facility was extended to May 28, 2015.
(10)
Represents repurchase agreement for Class A-2 and A-3 notes issued by Ocwen Real Estate Asset Liquidating Trust 2007-1 which have a current face value of $22.4 million at September 30, 2014. This agreement has no stated credit limit and lending is determined for each transaction based on the acceptability of the securities presented as collateral.
Senior Unsecured Notes
On May 12, 2014, Ocwen completed the issuance and sale of $350.0 million of its 6.625% Senior Notes due 2019 (the Senior Unsecured Notes) in a private offering. We received net proceeds of $343.3 million from the sale of the Senior Unsecured Notes after deducting underwriting fees and offering expenses. The Senior Unsecured Notes are general senior unsecured obligations of Ocwen and will mature on May 15, 2019. Interest is payable semi-annually on May 15th and November 15th. The Senior Unsecured Notes are not guaranteed by any of Ocwen’s subsidiaries.
At any time prior to May 15, 2016, Ocwen may redeem all or a part of the Senior Unsecured Notes, upon not less than 30 nor more than 60 days’ notice, at a redemption price equal to 100.0% of the principal amount of the Senior Unsecured Notes redeemed, plus the Applicable Premium as defined in the related indenture agreement (the Indenture), plus accrued and unpaid interest and Additional Interest as defined in the Indenture, if any, on the Senior Unsecured Notes redeemed. The Additional Premium on a Note is the greater of 1% of the principal amount of the Note or the redemption price at May 15, 2016 plus all interest due from the redemption date through May 15, 2016, less the principal amount of the Note. Additional Interest is earned by the Senior Unsecured Notes if the deadline for exchange or registration of the Senior Unsecured Notes is not met and ranges from an initial 0.25% to a maximum 1.0%.
On or after May 15, 2016, Ocwen may redeem all or a part of the Senior Unsecured Notes, upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as percentages of principal amount) specified in the Indenture plus accrued and unpaid interest and Additional Interest, if any. The redemption prices during the twelve-month periods beginning on May 15th of each year are as follows:
Year
 
Redemption Price
2016
 
104.969%
2017
 
103.313%
2018 and thereafter
 
100.000%

At any time prior to May 15, 2016, Ocwen may, at its option, use the net cash proceeds of one or more Equity Offerings as defined in the Indenture to redeem up to 35% of the principal amount of all Senior Unsecured Notes issued at a redemption price equal to 106.625% of the principal amount of the Senior Unsecured Notes redeemed plus accrued and unpaid interest and Additional Interest, if any, provided that: (i) at least 65% of the principal amount of all Senior Unsecured Notes issued under the Indenture remains outstanding immediately after any such redemption; and (ii) Ocwen makes such redemption not more than 120 days after the consummation of any such Equity Offering.
Upon the occurrence of a change of control as defined in the Indenture, Ocwen is required to make an offer to the holders of the Senior Unsecured Notes to repurchase the Senior Unsecured Notes at a purchase price equal to 101.0% of the principal amount of the Senior Unsecured Notes purchased plus accrued and unpaid interest and Additional Interest, if any. Each holder will have the right to require that the Ocwen purchase all or a portion of the holder’s Senior Unsecured Notes pursuant to the offer.
The Indenture contains various covenants that could, unless certain conditions are met, limit or restrict the ability of Ocwen and its subsidiaries to engage in specified types of transactions. Among other things, these covenants could potentially limit or restrict the ability of Ocwen and its subsidiaries to:
incur additional debt or issue preferred stock;
pay dividends or make distributions on or purchase equity interests of Ocwen;
repurchase or redeem debt that is subordinate to the Senior Unsecured Notes prior to maturity;
make investments or other restricted payments;
create liens on assets to secure debt of Ocwen or any guarantor of the Senior Unsecured Notes;
sell or transfer assets;
enter into transactions with “affiliates” (any entity that controls, is controlled by or is under common control with Ocwen or certain of its subsidiaries); and
enter into mergers, consolidations, or sales of all or substantially all of Ocwen’s assets.
Many of the restrictive covenants will be suspended if the Senior Unsecured Notes achieve an investment grade rating from both Moody’s Investors Service, Inc. (Moody’s) and Standard & Poor’s Ratings Services (S&P) and no default or event of default, as specified in the Indenture, has occurred and is continuing. However, covenants that are suspended as a result of achieving these ratings will again apply if Moody’s or S&P withdraws its investment grade rating or downgrades the rating assigned to the Senior Unsecured Notes below an investment grade rating.
Ocwen contemporaneously entered into a Registration Rights Agreement under which it agreed for the benefit of the initial purchasers of the Senior Unsecured Notes to use commercially reasonable efforts to file a registration statement and to have the registration statement become effective on or prior to 270 days after the closing of the offering. The registration statement would relate to a registered offer to exchange the Senior Unsecured Notes for other notes (referred to as the exchange notes) that would be issued by Ocwen, would be registered with the SEC and would have substantially identical terms as the Senior Unsecured Notes. If Ocwen is not able to effect the exchange offer, it will instead use commercially reasonable efforts to file and cause to become effective a shelf registration statement relating to resales of the Senior Unsecured Notes.
In connection with our issuance of the Senior Unsecured Notes, we incurred certain costs that we capitalized and are amortizing over the period from the date of issuance to May 15, 2019. The unamortized balance of these issuance costs was $6.1 million at September 30, 2014.
Covenants
Match funded liabilities and other secured borrowings are collateralized by specific assets. Under the terms of these borrowing agreements, we are subject to various qualitative and quantitative covenants. Collectively, these covenants include:
Specified net worth requirements;
Restrictions on future indebtedness; and
Monitoring and reporting of various specified transactions or events, including specific reporting on defined events affecting collateral underlying certain borrowing agreements.
Financial covenants in our borrowing agreements require that we maintain consolidated tangible net worth, the most restrictive of which is $630.0 million plus 65% of quarterly net income, without adjustment for quarterly net losses, beginning with the three months ended December 31, 2012. The required consolidated tangible net worth in connection with this agreement was $957.1 million at September 30, 2014. Should we fail to be in compliance with these requirements, remedies include but are not limited to, at the option of the facility provider, termination of further funding, acceleration of outstanding obligations, enforcement of liens against the assets securing or otherwise supporting the agreement, and other legal remedies. Our lenders can waive their contractual rights in the event of a default. Our borrowing agreements generally include cross default provisions such that a default under one agreement could trigger defaults under other agreements. We believe that we are in compliance with all of our qualitative and quantitative covenants at the date of these financial statements.